Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Zidovudine | Increase | Positive | 307 | ||||||
| Acyclovir | Increase | Positive | 307 | ||||||
| Ganciclovir | Increase | Positive | 307 | ||||||
| Zalcitabine | Increase | Positive | 307 | ||||||
| amphotericin B | 2.5mg/ml | Aspergillus fumigatus | oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t | induce | Positive | 304 | |||
| Terbinafine | 4mg/ml | Aspergillus fumigatus | oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t | induce | Positive | 304 | |||
| itraconazole | 4mg/ml | Aspergillus fumigatus | oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t | induce | Positive | 304 | |||
| P110 | 1 µM | 2hr | SH-SY5Y cells were treated with P110 (1 µM) followed by incubation of MPP+ (2 mM) for 2 hours. | Mitochondrial superoxide production was determined using the mitochondrial superoxide indicator MitoSOX Red. Total ROS production was determined in SH-SY5Y cells using CM2-HDCFA. | reduce | Positive | 310 | ||
| Clofibrate | Positive | 185 | |||||||
| Amiodarone | Positive | 185 | |||||||
| neomycin | 50 μM | zebrafish | zebrafish lateral line hair | use ROS indicator dye cellROX green ( it labels a number of intracellular compartments, including cytoplasm, nucleus, and mitochondria) | increase | Positive | 315 | ||
| Staurosporine | 2 µM | 24hr | U2OS | mt-roGFP and mitoSOX | increase | Positive | 313 | ||
| camptothecin | 30 µM | 24hr | U2OS | mt-roGFP and mitoSOX | increase | Positive | 313 | ||
| Menadione | 20 µM | 24hr | U2OS | mt-roGFP and mitoSOX | increase | Positive | 313 | ||
| Cisplatin | 150 µM | 24hr | U2OS | U2OS cells stably expressing mt-roGFP and HyPer-red targeted at mitochondria | increase | Positive | 313 | ||
| camptothecin | 30 µM | 24hr | U2OS | U2OS cells stably expressing mt-roGFP and HyPer-red targeted at mitochondria | increase | Positive | 313 | ||
| Ciprofloxacin | Increase | Positive | 307 | ||||||
| Mitoquinone | U2OS | mt-roGFP ratio change (Quantitative representation of the percentage of cell death in cells pre-treated with MitoQ followed by drug treatment or drug alone as indicated for 24 h) | reduce | Positive | 313 | ||||
| Cisplatin | Increase | Positive | 307 | ||||||
| Cyclophosphamide | Increase | Positive | 307 | ||||||
| Gentamicin | 5mM | 10min | rat | isolated rat liver (and kidney) mitochondria | Mitochondrial ROS production can be measured using Amplex Red, a dye that fluoresces dependent on hydrogen peroxide (H2O2) levels. | reduce | Positive | 316 | |
| glyceraldehyde 3-phosphate | 2.5mM | decrease | Positive | 162 | |||||
| dihydroxyacetone phosphate | decrease | Positive | 162 | ||||||
| Berberine | 25 μM | 6, 24 hr | K1735-M2 mouse melanoma cells | CM-H2DCFDA (DCF), a fluorescent probe for oxidative stress (epifluorescence microscope) | increase | Positive | 327 | ||
| Acetaminophen | increase | Positive | 35 | ||||||
| Menadione | increase | Positive | 35 | ||||||
| Troglitazone | human | hepatocytes | cell viability assay | Positive | 226 | ||||
| CGP37157 | 1 μmol/L | rat | ventricular myocytes | redox-sensitive OMM-HyPer and ERroGFP_iE biosensors | Positive | 241 | |||
| kaempferol | 10 μmol/L | rat | ventricular myocytes | redox-sensitive OMM-HyPer and ERroGFP_iE biosensors | Positive | 241 | |||
| MitoTEMPO | 20 μmol/L | Positive | 241 | ||||||
| Amiodarone | 1 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | p < 0.05 | 4 |
| Amiodarone | 100 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | p < 0.05 | 4 |
| benzarone | 10 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | started to be detectable | 4 |
| benzarone | 100 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | p < 0.01 | 4 |
| benzbromarone | 0.1 nmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | started to be detectable | 4 |
| benzbromarone | 0.1 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | p < 0.05 | 4 |
| benzbromarone | 1 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | p < 0.01 | 4 |
| benzbromarone | 100 μmol/L | 1 hour | human | HepG2 | Measurement of ROS | increase | Positive | p < 0.01 | 4 |
| Sulindac | increase | Positive | 45 | ||||||
| Diflunisal | 558 | rat | hepatocytes | use CM-H2DCFDA to monitor reactive oxygen species | Positive | AC50 (μM) | 40 | ||
| Sulindac sulfide | 109 | rat | hepatocytes | use CM-H2DCFDA to monitor reactive oxygen species | Positive | AC50 (μM) | 40 | ||
| Nimesulide | 574 | rat | hepatocytes | use CM-H2DCFDA to monitor reactive oxygen species | Positive | AC50 (μM) | 40 | ||
| Acetaminophen | Positive | 243 | |||||||
| Acetylcysteine | rho-GFP (Redox-sensitive GFP) | Positive | 244 | ||||||
| Amitriptyline | Positive | 197 | |||||||
| Desipramine | Positive | 197 | |||||||
| Valproic Acid | increase | Positive | 197 | ||||||
| Doxorubicin | increase | Positive | 197 | ||||||
| Efavirenz | increase | Positive | 197 | ||||||
| Propofol | increase | Positive | 197 | ||||||
| Ketamine | increase | Positive | 197 | ||||||
| Paraquat | 10 mg/kg/week intraperitoneal (i.p.) | 4 weeks | C57BL/6 mice | Positive | 242 | ||||
| Paraquat | 250 μM | 5min | Sprague Dawley rat | brain cultures | Positive | 242 | |||
| Rotenone | 0.1–0.5 nmol/mg protein | Wistar rat | brain isolated mitochondria | increase | Positive | 242 | |||
| Manganese | 0.1–10 μM | Sprague Dawley rat astrocytes and microglia cell culture | reduce | Positive | 242 | ||||
| Manganese | 15 mg/l in drinking water | Swiss Albino mice | increase | Positive | 242 | ||||
| Aluminium | 10 mg/kg/day intragastric for 12 weeks | Wistar rats | Positive | 242 | |||||
| Methylmercury | 15 mg/l in drinking water | Swiss albino mice | Positive | 242 | |||||
| Ethanol | rat | liver | Positive | 259 | |||||
| Acetaminophen | Positive | 258 | |||||||
| Doxorubicin | Positive | 250 | |||||||
| Etomoxir | 5 μM | T cell | Positive | 257 | |||||
| Ubidecarenone | Positive | 248 | |||||||
| Mitoquinone | Positive | 248 | |||||||
| Acetaminophen | 300 mg/kg | 3 hours | mice; C57Bl/6 | in vivo | ALT activity measurement | increase | Positive | p < 0.05 | 1 |
| Acetaminophen | 300 mg/kg | 6 hours | mice; C57Bl/6 | in vivo | ALT activity measurement | increase | Positive | p < 0.05 | 1 |
| Cadmium | 50, 100 μM | HPNE cell (human pancreatic Nestin-expressing cells) | oxidative stress was assessed by measuring DCF fluorescence | increase | Positive | 334 | |||
| Cadmium | 50, 100 μM | AsPC-1 cells (pancreatic tumor cells) | oxidative stress was assessed by measuring DCF fluorescence | increase | Positive | 334 | |||
| Acetaminophen | 1.5 g/kg | 24 hours | rat; Fischer (F344) | in vivo | ALT activity measurement | increase | Positive | p < 0.05 | 1 |
| Acetaminophen | 300 mg/kg | 24 hours | mice; C57Bl/6 | in vivo | ALT activity measurement | increase | Positive | p < 0.05 | 1 |
| Acetylsalicylic acid | 10 μmol/ml | 24 hours | human | HepG2 | ROS measurement | increase | Positive | p < 0.05 | 2 |
| Acetylsalicylic acid | 10 μmol/ml | 48 hours | human | HepG2 | ROS measurement | increase | Positive | p < 0.05 | 2 |
| Nimesulide | 1 mM | rat; Sprague-Dawley Crl:CD (SD) BR | lung microsomes | adrenochrome assay (Misra and Fridovich, 1972) | increase | Positive | p < 0.05 | 11 | |
| Nimesulide | 0.5 mM | 20 minutes | rat; Sprague-Dawley Crl:CD (SD) BR | lung microsomes | horseadish preoxidase method (Green and Hill, 1984) | increase | Positive | p < 0.05 | 11 |
| Rotenone | 100 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| tacrolimus | 50 µg/ml | 12hr | INS-1 cells | MitoSOX Red staining to detect mitochondrial superoxide anion (O2−) levels by flow cytometric analysis and e time-lapse images of cells treated for 12 h with MitoSOX Red. | induce | Positive | 322 | ||
| Paraquat | 10 mM | yeast; EG110 (MnSOD knock-out) | mitochondria | Measurement of superoxide anion; Used ethanol (5 mM) as substrate | increase | Positive | 14 | ||
| Paraquat | 10 mM | yeast; EG103 (Wild-type) | mitochondria | Measurement of superoxide anion; Used ethanol (5 mM) as substrate | increase | Positive | 14 | ||
| Paraquat | 1 mM | 10 minutes | rat | isolated heart mitochondria | Measurement of superoxide anion; Used glutamate/malate (5 mM) as substrate | increase | Positive | 14 | |
| Paraquat | 0.1 mM | 10 minutes | rat | isolated heart mitochondria | Measurement of superoxide anion; Used succinate (5 mM) as substrate | increase | Positive | 14 | |
| Paraquat | 1 mM | 10 minutes | rat | isolated heart mitochondria | Measurement of hydrogen peroxide; Used glutamate/malate (5 mM) as substrate | increase | Positive | 14 | |
| Paraquat | 1 mM | 10 minutes | rat | isolated heart mitochondria | Measurement of hydrogen peroxide; Used succinate (5 mM) as substrate | increase | Positive | 14 | |
| MG-132 | 20 μM | 24 hr | rat | PC12 cells | Measurement of intracellular ROS formation with DCFH2-DA | increase | Positive | 289 | |
| 3-morpholinosydnonimine | 150 μM | 24 hr | rat | PC12 cells | Measurement of intracellular ROS formation with DCFH2-DA | decrease | Positive | 289 | |
| Cisplatin | 84.96 ± 3, 158.9 ± 8.2, 372.7 ± 17.5 and 499.5 ± 15.1 μM | 24 hr | Ishikawa, MDA-MB-231, PC-3 and Caco-2 | Intracellular ROS (a) and mitochondrial superoxide were measured by fluorescence intensity of H2DCFDA and MitoSOX respectively. | increase | Positive | IC50 | 299 | |
| Dequalinium Chloride | 14.24 ± 0.59, 57.85 ± 3.59, 93.31 ± 3.21 and 179.2 ± 5.2 μM | 24 hr | Ishikawa, MDA-MB-231, PC-3 and Caco-2 | Intracellular ROS (a) and mitochondrial superoxide were measured by fluorescence intensity of H2DCFDA and MitoSOX respectively. | increase | Positive | IC50 | 299 | |
| Metformin | 1 mM | 24 hours | human | hepatocytes | ROS measurement | increase | Positive | 15 | |
| Metformin | 2 mM | 24 hours | human | hepatocytes | ROS measurement | increase | Positive | 15 | |
| buformin | 75 μM | 24 hours | human | hepatocytes | ROS measurement | increase | Positive | 15 | |
| Phenformin | 12.5 μM | 24 hours | human | hepatocytes | ROS measurement | increase | Positive | 15 | |
| Amiodarone | 10 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Chlorpromazine | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Cyclosporin A | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| imipramine | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Maprotiline | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Metformin | 1 mM | 24 hours | human | hepatocytes | Measurement of mitochondrial membrane potential | affect | Positive | 15 | |
| Metformin | 2 mM | 24 hours | human | hepatocytes | Measurement of mitochondrial membrane potential | affect | Positive | 15 | |
| buformin | 75 μM | 24 hours | human | hepatocytes | Measurement of mitochondrial membrane potential | affect | Positive | 15 | |
| Phenformin | 12.5 μM | 24 hours | human | hepatocytes | Measurement of mitochondrial membrane potential | affect | Positive | 15 | |
| Tamoxifen | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Troglitazone | 10 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| atorvastatin | 100 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Cerivastatin | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| fluvastatin | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| lovastatin | 10 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| pravastatin | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Simvastatin | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |